It is a food and beverages private limited company based in Malkajgiri, Telangana, India, established in 2016.
2016 | Malkajgiri, Telangana, India | ActiveCuresun Pharma Private Limited, a active private limited company, was established on 06 July 2016 in Malkajgiri, Telangana, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24304TG2016PTC110729. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Balusu Harika (Additional Director), Anusha Kantamaneni (Additional Director), Sivakrishna Srinivas Kumar Pilla (Additional Director). Past directors included Venkateshwara Reddy Karnati, Chandra Kala Sangepu. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F No.105,Block-A,Ground Floor H.No.42-767/1/A/105 Plot No. 62,Sashank Resdiency S.P.Nagar,, Moula-Ali, Malkajgiri, Telangana, 500040.
U24304TG2016PTC110729
110729
06 July 2016
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Curesun Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balusu Harika | Additional Director | 26 Jul 2023 | Current |
| Anusha Kantamaneni | Additional Director | 26 Jul 2023 | Current |
| Sivakrishna Srinivas Kumar Pilla | Additional Director | 26 Jul 2023 | Current |
| Sreedhar Kodipyaka | Additional Director | 21 May 2019 | Current |
| Jyothi Konudula | Director | 06 Jul 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 May 2019 | Past |
| Pramod Abcsdd | Director | 12 Apr 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curesun Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 130.74% decrease in profit. The company's net worth dipped by a decrease of 3.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Curesun Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Curesun Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curesun Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curesun Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Curesun Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Curesun Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity Balusu Harika was appointed as a Additional Director was appointed as a Additional Director on 26 Jul 2023 & has been associated with this company since 2 years 5 months . was completed.
Progress on Anusha Kantamaneni was appointed as a Additional Director was appointed as a Additional Director on 26 Jul 2023 & has been associated with this company since 2 years 5 months . was documented.
Sivakrishna Srinivas Kumar Pilla was appointed as a Additional Director was appointed as a Additional Director on 26 Jul 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.
Sreedhar Kodipyaka was appointed as a Additional Director was appointed as a Additional Director on 21 May 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
The CIN of Curesun Pharma Private Limited is U24304TG2016PTC110729.
Curesun Pharma Private Limited is headquartered at F No.105,Block-A,Ground Floor H.No.42-767/1/A/105 Plot No. 62,Sashank Resdiency S.P.Nagar,, Moula-Ali, Malkajgiri, Telangana, 500040.
Curesun Pharma Private Limited was incorporated on 06 July 2016.
The current directors of Curesun Pharma Private Limited are
The primary industry of Curesun Pharma Private Limited is Food And Beverages.
Curesun Pharma Private Limited is unlisted.
The authorized capital of Curesun Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Curesun Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX